COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

@article{To2020COVID19RB,
  title={COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing},
  author={Kelvin Kai-Wang To and Ivan F.N. Hung and Jonathan Daniel Ip and Allen Wing-Ho Chu and Wan-Mui Chan and Anthony Raymond Tam and Carol Ho-Yan Fong and Shuofeng Yuan and Hoi‐wah Tsoi and Anthony Chin-Ki Ng and Larry Lee and Polk Wan and Eugene Yuk-Keung Tso and Wing-kin To and Dominic N. C. Tsang and Kwok-Hung Chan and Jian-Dong Huang and Kin-Hang Kok and Vincent Chi-Chung Cheng and Kwok Yung Yuen},
  journal={Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America},
  year={2020}
}
  • K. To, I. Hung, K. Yuen
  • Published 25 August 2020
  • Biology, Medicine
  • Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Abstract Background Waning immunity occurs in patients who have recovered from COVID-19. However, it remains unclear whether true re-infection occurs. Methods Whole genome sequencing was performed directly on respiratory specimens collected during two episodes of COVID-19 in a patient. Comparative genome analysis was conducted to differentiate re-infection from persistent viral shedding. Laboratory results, including RT-PCR Ct values and serum SARS-CoV-2 IgG, were analyzed. Results The second… 
View on PubMed
academic.oup.com
464 Citations
Highly Influential Citations
19
Background Citations
166
Methods Citations
9
Results Citations
18

464 Citations

Viral Haplotypes in COVID-19 Patients Associated With Prolonged Viral Shedding
TLDR
It is shown that haplotype diversity of SARS-CoV-2 may result in viral adaptation for persistent shedding in multiple recurrences of COVID-19 patients, who met the discharge requirement.
Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients
TLDR
This review begins with an overview of SARS-CoV-2 morphology and replication and summarizes what is known to date about the detection of the virus in nasal, oropharyngeal, and fecal specimens of patients who have recovered from COVID-19, with a focus on the factors thought to contribute to prolonged detection.
Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India
TLDR
Reinfections in two patients are confirmed and weak evidence of reinfection in the third patient is provided, unable to rule out a prolonged infection in the fourth and emphasized the importance of detailed analyses of clinical and serological information as well as the virus's genomic variations while assessing cases of SARS-CoV-2 reinfections.
Symptomatic SARS-CoV-2 re-infection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response.
TLDR
If this case is representative of most Covid-19 patients, long-lived protective immunity against SARS-CoV-2 might not be likely, and whole genome sequencing was performed to detect potential transmission clusters.
Intra-host evolution during SARS-CoV-2 persistent infection
TLDR
A dynamic and complex landscape of host and pathogen interaction during persistent infection is highlighted suggesting that the host's innate immunity shapes the increase of intra-host diversity with possible implications for therapeutic strategies and public health decisions during the COVID-19 pandemic.
Whole Genome Sequencing Confirmed SARS-CoV-2 Reinfections Among Healthcare Workers in India with Increased Severity in the Second Episode
TLDR
Genomic variations observed through whole genome sequencing coupled with clinical presentation confirm reinfections of SARS-CoV-2 in healthcare workers.
Genomic evidence for reinfection with SARS-CoV-2: a case study
Partial N Gene Sequencing for SARS-CoV-2 Verification and Pathway Tracing
TLDR
Using this sequencing-based method to re-test 9 reference nasopharyngeal swab samples supplied by the Connecticut State Department of Public Health Microbiology Laboratory revealed that 2 of the 9 positive samples had a single nucleotide mutation in the 398-base segment of the SARS-CoV-2 N gene.
Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19
SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses
...
...

References

SHOWING 1-10 OF 44 REFERENCES
Prolonged Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA in an Obstetric Patient With Antibody Seroconversion.
TLDR
Prolonged viral shedding of SARS-CoV RNA may occur in the pregnant patient, and this complicates the interpretation of a positive SAR'sCoV-2 RT-PCR test result in the asymptomatic gravid patient.
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
TLDR
Most convalescent plasma samples obtained from individuals who recover from COVID-19 do not contain high levels of neutralizing activity, and rare but recurring RBD-specific antibodies with potent antiviral activity were found in all individuals tested, suggesting that a vaccine designed to elicit such antibodies could be broadly effective.
Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation
TLDR
A cohort study on the follow-up of 182 recovered patients under medical isolation observation found that COVID-19 responds well to treatment, and most of the re-positives turned negative in the following tests, and all of them carried antibodies against SARS-CoV-2.
The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera
TLDR
Using pseudovirus-based assay, it is found that S-D614 and S-G614 protein pseudotyped viruses share a common receptor, human angiotensin-converting enzyme 2 (ACE2), which could be blocked by recombinant ACE2 with the fused Fc region of human IgG1.
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
TLDR
A rational and dynamic virus nomenclature that uses a phylogenetic framework to identify those lineages that contribute most to active spread and is designed to provide a real-time bird’s-eye view of the diversity of the hundreds of thousands of genome sequences collected worldwide.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
TLDR
Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity.
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
TLDR
A cohort of asymptomatic patients infected with SARS-CoV-2 had significantly lower levels of virus-specific IgG antibodies compared to a cohort of age- and sex-matched symptomatic infected patients.
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
TLDR
CD4 + T cells that are reactive against the spike glycoprotein of SARS-CoV-2 in the peripheral blood of patients with COVID-19 and healthy donors are found, indicating that spike-protein cross-reactive T cells are present and probably generated during previous encounters with endemic coronaviruses.
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
TLDR
Data show that SARS-CoV-2 infection induced protective immunity against reexposure in nonhuman primates, and these findings have key implications for public health and economic initiatives if validated in human studies.
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
...
...